Neuromyelitis Optica Spectrum Disorder in a Chinese Woman with Ocular Myasthenia Gravis: First Reported Case in the Chinese Population

References

• Bedi G, Usmani N, Delgado S, Sheremata W. Prevalence and ethnic origin of patients with neuromyelitis optica in South Florida. Mult Scler 2009;15:S34
   Google Scholar
• Cabrera-Gomez JA, Kurtzke JF, Gonzalez-Quevedo A, Lara-Rodríguez R. An epidemiological study of neuromyelitis optica in Cuba. J Neurol 2009;256:35–44
   PubMed Web of Science ®Google Scholar
• Rivera JF, Kurtzke JF, Booth VJ, Corona VT 5th. Characteristics of Devic’s disease (neuromyelitis optica) in Mexico. J Neurol 2008;255:710–715
   PubMed Web of Science ®Google Scholar
• Cabre P, Heinzlef O, Merle H, Buisson GG, Bera O, Bellance R, Vernant JC, Smadja D. MS and neuromyelitis optica in Martinique (French West Indies). Neurology 2001;56:507–514
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485–1489
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM. Evidence for humoral autoimmunity in neuromyelitis optica [review]. Neurol Res 2006;28:348–353
   PubMed Web of Science ®Google Scholar
• Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106–2112
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Weinshenker BG. Neuromyelitis optica. Curr Treat Options Neurol 2008;10:55–66
   PubMed Web of Science ®Google Scholar
• Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, Du Pasquier RA, Polman CH, Sorensen PS, Hemmer B. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 2010;17:1019–1032
   PubMed Web of Science ®Google Scholar
• Jarius S, Paul F, Franciotta D, de Seze J, Münch C, Salvetti M, Ruprecht K, Liebetrau M, Wandinger KP, Akman-Demir G, Melms A, Kristoferitsch W, Wildemann B. Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler 2012;18:1135–1143
   PubMed Web of Science ®Google Scholar
• Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992;326:581–588
   PubMed Web of Science ®Google Scholar
• Chan KH, Jason SC Kwan, Philip WL Ho, Jessica WM Ho, Andrew CY Chu, David B Ramsden. Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays. J Neuroinflamm 2010,7:50. doi: 10.1186/1742-2094-7-50
   Google Scholar
• Misu T, Fujihara K, Itoyama Y. Neuromyelitis optica and anti-aquaporin 4 antibody—an overview. Brain Nerve 2008;60:527–537
   PubMedGoogle Scholar
• Fazio R, Malosio ML, Lampasona V, De Feo D, Privitera D, Marnetto F, Centonze D, Ghezzi A, Comi G, Furlan R, Martino G. Antiaquaporin 4 antibodies detection by different techniques inneuromyelitis optica patients. Mult Scler 2009;15:1153–1163
   PubMed Web of Science ®Google Scholar
• Waters P, Vincent A. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J 2008;15:99–105
   PubMedGoogle Scholar
• McKeon A, Lennon VA, Jacob A, Matiello M, Lucchinetti CF, Kale N, Chan KH, Weinshenker BG, Apiwattinakul M, Wingerchuk DM, Pittock SJ. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve 2009;39:87–90
   PubMed Web of Science ®Google Scholar
• Leite MI, Coutinho E, Lana-Peixoto M, Apostolos S, Waters P, Sato D, Melamud L, Marta M, Graham A, Spillane J, Villa AM, Callegaro D, Santos E, da Silva AM, Jarius S, Howard R, Nakashima I, Giovanni G, Buckley C, Hilton-Jones D, Vincent A, Palace J. Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 2012;78:1601–1607
   PubMed Web of Science ®Google Scholar
• Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006;63:964–968
   PubMed Web of Science ®Google Scholar
• Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, Calabresi PA, Kerr DA. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 2009;73:302–308
   PubMed Web of Science ®Google Scholar
• Yau GSK, Lee JWY, Lau PPK, Tam VTY, Wong WWY, Yuen CYF. Prospective study on retinal nerve fibre layer thickness changes in isolated unilateral retrobulbar optic neuritis. Sci World J Epub ahead of print 21 Oct 2013; Article ID 694613, doi:10.1155/2013/694613
   Google Scholar
• Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B, Lebrun C, Moreau T, Vermersch P, Fontaine B, Lyon-Caen O, Gout O. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 2007;13:256–259
   PubMed Web of Science ®Google Scholar